Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.5K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.5K
G Protein-coupled Receptors01:15

G Protein-coupled Receptors

15.7K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
15.7K
The Two-State Receptor Model01:29

The Two-State Receptor Model

2.9K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
2.9K
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

1.6K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.6K
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

3.5K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
3.5K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

7.1K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
7.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

TBL1XR1 mutations promoted tumor progression in diffuse large B-cell lymphoma through impairing nature killer cytotoxicity via the MYC-CD47/PD-L1 axis.

Molecular cancer·2026
Same author

Locoregional recurrence patterns and prognostic outcomes in early-stage natural killer/T-cell lymphoma treated with sandwich chemoradiotherapy: A post hoc analysis of a randomized controlled trial.

Practical radiation oncology·2026
Same author

LncRNA IRENA promotes peripheral T-cell lymphoma progression through scaffolding ARHGEF1 and FMNL1 to modulate RHOA GTPase/MAPK signaling.

Oncogene·2026
Same author

A Biophysical Prior-Based Hierarchical Graph Pooling Strategy for Protein Function Prediction.

IEEE transactions on computational biology and bioinformatics·2026
Same author

Tumour-Derived Extracellular Vesicles Induce Diffuse Large B-Cell Lymphoma Progression Through Macrophage-Mediated MDSC Accumulation.

Journal of extracellular vesicles·2026
Same author

Ultrasound-Guided Drug Injection Combined With Suprascapular Nerve Pulsed Radiofrequency for Post-Stroke Hemiplegic Shoulder Pain: A Randomized Controlled Trial.

American journal of physical medicine & rehabilitation·2026

Related Experiment Video

Updated: Dec 13, 2025

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
07:16

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission

Published on: August 16, 2018

13.9K

The Quantitative Structure-Activity Relationships between GABAA Receptor and Ligands based on Binding Interface

Shu Cheng1, Yanrui Ding1

  • 1School of Science, Jiangnan University, Wuxi, Jiangsu, 214122,China.

Current Computer-Aided Drug Design
|July 28, 2020
PubMed
Summary

This study developed a Quantitative Structure Activity Relationship (QSAR) model to predict ligand binding to the GABAA receptor. The model accurately predicts ligand activity using key molecular descriptors and interaction characteristics.

Keywords:
GABAAGBRTQSARligand-receptor interaction characteristicsmean decrease impuritypIC50random forests

More Related Videos

Quantifying Agonist Activity at G Protein-coupled Receptors
11:45

Quantifying Agonist Activity at G Protein-coupled Receptors

Published on: December 26, 2011

19.7K
Using an α-Bungarotoxin Binding Site Tag to Study GABA A Receptor Membrane Localization and Trafficking
11:57

Using an α-Bungarotoxin Binding Site Tag to Study GABA A Receptor Membrane Localization and Trafficking

Published on: March 28, 2014

16.2K

Related Experiment Videos

Last Updated: Dec 13, 2025

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
07:16

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission

Published on: August 16, 2018

13.9K
Quantifying Agonist Activity at G Protein-coupled Receptors
11:45

Quantifying Agonist Activity at G Protein-coupled Receptors

Published on: December 26, 2011

19.7K
Using an α-Bungarotoxin Binding Site Tag to Study GABA A Receptor Membrane Localization and Trafficking
11:57

Using an α-Bungarotoxin Binding Site Tag to Study GABA A Receptor Membrane Localization and Trafficking

Published on: March 28, 2014

16.2K

Area of Science:

  • Computational chemistry
  • Pharmacology
  • Machine learning

Background:

  • Quantitative Structure Activity Relationship (QSAR) methods are crucial for predicting biological effects using machine learning.
  • Understanding ligand interactions with the Gamma-Aminobutyric Acid A (GABAA) receptor is vital for drug development.

Purpose of the Study:

  • To develop a QSAR model for ligands targeting the human GABAA receptor.
  • To incorporate binding interface characteristics into the QSAR modeling process.

Main Methods:

  • Feature selection using Mean Decrease Impurity identified 53 key molecular descriptors from 1,286.
  • Gradient Boosting Regression Trees were employed to build three QSAR models.
  • Models integrated molecular descriptors and ligand-receptor interaction features.

Main Results:

  • The optimal QSAR model achieved a Leave-One-Out-Cross-Validation (Q2 LOO) of 0.8974 and R2 of 0.9261.
  • The model demonstrated high accuracy in predicting pIC50 values for new ligands, with minimal error.
  • Key features identified include BELm2, BELe2, MATS1m, X5v, Mor08v, and Mor29m.

Conclusions:

  • The developed QSAR model accurately predicts ligand activity at the GABAA receptor.
  • Specific molecular descriptors and interaction features are critical for accurate QSAR model construction.
  • This approach enhances the prediction of ligand efficacy for GABAA receptor modulators.